세계의 시퀀싱 시약 시장 : 시장 규모, 점유율, 동향 분석 보고서-유형별, 기술별, 용도별, 최종 용도별, 지역별, 전망 및 예측(2024-2031년)

The Global Sequencing Reagents Market size is expected to reach $24.45 billion by 2031, rising at a market growth of 17.5% CAGR during the forecast period.

The oncology segment leads the market due to the critical role of sequencing technologies in cancer research, diagnosis, and treatment. The ability to perform detailed genetic profiling of tumors allows researchers and clinicians to identify mutations and develop targeted therapies. The increasing incidence of cancer globally, coupled with the transition towards precision medicine, serves as a significant impetus for the utilization of sequencing applications in the field of oncology. Additionally, advancements in sequencing technologies have made these tools indispensable for identifying biomarkers and monitoring treatment responses. The oncology segment witnessed 30% revenue share in the market in 2023.

The major strategies followed by the market participants are Partnership as the key developmental strategy to keep pace with the changing demands of end users. For instance, In 2024, April, Bio-Rad Laboratories, Inc. partnered with Allegheny Health Network to research the use of Bio-Rad's Droplet Digital PCR (ddPCR) technology for monitoring molecular residual disaease (MRD) in solid tumors. This partnership would enhance sensitivity and precision in detecting MRD, potentially improving patient outcomes through earlier and more accurate monitoring. Moreover, In 2024, March, Eurofins Scientific SE announced the partnership with MGI Tech marking the first European corporate order of the T20 ultra-high throughput sequencer. This partnership aims to enhance precision health initiatives, providing cost-effective sequencing for global research, including WGS, stLFR, and single-cell sequencing, boosting personalized medicine.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly negatively impacted the sequencing reagents market, especially during its initial phases. Supply chain disruptions due to manufacturing halts and transportation restrictions caused delays in producing and delivering critical reagents, leading to shortages in laboratories worldwide. Many research and diagnostic projects unrelated to COVID-19 were postponed or canceled as resources were redirected toward pandemic-related studies. Since the positive factors surpassed the negative aspects, the pandemic supported the overall growth trajectory of the market.

Market Growth Factors

The adoption of sequencing technologies in clinical diagnostics has revolutionized the healthcare landscape, offering unprecedented insights into various diseases' genetic and molecular underpinnings. One of the most significant areas of growth is in the diagnosis of genetic disorders. Traditional methods of identifying genetic abnormalities, such as karyotyping or fluorescence in situ hybridization (FISH), often lacked the resolution to detect subtle or rare mutations.

Additionally, the increasing investment in genomic research by governments, research institutions, and private organizations has been pivotal in advancing the field of genomics and its applications. Governments worldwide fund large-scale initiatives, such as the All of Us Research Program by the NIH and the Human Genome Project 2.0, which aim to map genetic diversity and personalize medical treatments. Thus, such immense support from governments will drive the market's growth.

Market Restraining Factors

While technological advancements have considerably reduced the cost of sequencing compared to its early years, it remains prohibitively expensive for many institutions and researchers. The initial investment required for purchasing state-of-the-art sequencing equipment and the recurring expenses of reagents and consumables place these technologies out of reach for smaller laboratories and institutions with limited funding. Hence, the high cost of sequencing technologies and reagents continues to be a significant barrier to their widespread adoption.

Technology Outlook

Based on technology, the market is classified into sanger sequencing, next-generation sequencing, and third generation sequencing. The third-generation sequencing segment procured 11% revenue share in the market in 2023. Third-generation sequencing technologies, such as single-molecule real-time (SMRT) sequencing and nanopore sequencing, are gaining traction due to their ability to produce long-read sequences and provide real-time data.

Type Outlook

On the basis of type, the market is divided into library kits, template kits, control kits, sequencing kits, and others. The library kits segment recorded 27% revenue share in the market in 2023. The demand for library kits is driven by their essential function in preparing DNA or RNA samples for sequencing, ensuring high-quality and reliable data output.

Application Outlook

By application, the market is segmented into oncology, reproductive health, clinical investigation, agrigenomics & forensics, consumer genomics, and others. The consumer genomics segment garnered 10% revenue share in the market in 2023. Consumer genomics is driven by the increasing public interest in understanding personal genetic information. The growing availability of direct-to-consumer genetic testing kits, supported by advancements in sequencing technologies, has made these services more affordable and accessible.

End Use Outlook

Based on end use, the market is segmented into academic research, clinical research, hospitals & clinics, pharmaceutical & biotechnology companies, and others. The academic research segment acquired 48% revenue share in the market in 2023. This segment is propelled by the widespread adoption of sequencing technologies in universities and research institutions for genomic studies.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment garnered 26% revenue share in the market in 2023. Europe's market is driven by its strong research infrastructure and significant investments in genomics. The region's focus on advancing personalized medicine and precision healthcare has fueled the adoption of sequencing technologies in academic and clinical settings.

Recent Strategies Deployed in the Market

• Oct-2024: Illumina, Inc. has launched the MiSeq i100 Series, featuring the MiSeq i100 and i100 Plus Systems. These affordable, user-friendly benchtop instruments offer rapid sequencing with room-temperature storage, enabling same-day analysis. Building on the MiSeq legacy, they offer enhanced speed and simplicity for both seasoned and new labs.
• Apr-2024: Bio-Rad Laboratories, Inc. partnered with Allegheny Health Network to research the use of Bio-Rad's Droplet Digital PCR (ddPCR) technology for monitoring molecular residual disaease (MRD) in solid tumors. This partnership would enhance sensitivity and precision in detecting MRD, potentially improving patient outcomes through earlier and more accurate monitoring.
• Apr-2024: Bio-Rad Laboratories, Inc. released the ddPLEX ESR1 Mutation Detection Kit, a highly sensitive multiplexed digital PCR assay for detecting seven ESR1 mutations with 0.01% sensitivity. Compatible with the QX600 System, it provides rapid, simultaneous results from ctDNA or FFPE samples, enhancing oncology research and patient monitoring.
• Mar-2024: Eurofins Scientific SE announced the partnership with MGI Tech marking the first European corporate order of the T20 ultra-high throughput sequencer. This partnership aims to enhance precision health initiatives, providing cost-effective sequencing for global research, including WGS, stLFR, and single-cell sequencing, boosting personalized medicine.
• Oct-2023: F. Hoffmann-La Roche Ltd. teamed up with AWS, a cloud computing company, to integrate AI-powered tools into its Navify Digital Pathology platform. This partnership enhanced breast and prostate cancer diagnosis by improving accuracy, efficiency, and turnaround time in pathology labs, leveraging cloud infrastructure for scalability and security.
• Oct-2023: Revvity, Inc. teamed up with Element Biosciences, Inc. to streamline genomic sequencing workflows. Their collaboration enhances lab processes by offering integrated solutions, including sample collection, nucleic acid extraction, sequencing, and data analysis. The combined system aims to improve research efficiency and expand access to high-quality sequencing globally.

List of Key Companies Profiled

• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation (Beckman Coulter, Inc.)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Quest Diagnostics Incorporated
• Revvity, Inc.
• Eurofins Scientific SE
• Hologic, Inc.
• Illumina, Inc.

Global Sequencing Reagents Market Report Segmentation

By Type

• Sequencing Kits
• Library Kits
• Control Kits
• Template Kits
• Other Type

By Technology

• Next-Generation Sequencing
• Third Generation Sequencing
• Sanger Sequencing

By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• Consumer Genomics
• Other Application

By End Use

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Use

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Sequencing Reagents Market, by Type
  • 1.4.2 Global Sequencing Reagents Market, by Technology
  • 1.4.3 Global Sequencing Reagents Market, by Application
  • 1.4.4 Global Sequencing Reagents Market, by End Use
  • 1.4.5 Global Sequencing Reagents Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
• 4.3 Market Share Analysis, 2023
• 4.4 Top Winning Strategies
  • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
  • 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, Feb - 2024, Apr) Leading Players
• 4.5 Porter Five Forces Analysis

Chapter 5. Global Sequencing Reagents Market by Type

• 5.1 Global Sequencing Kits Market by Region
• 5.2 Global Library Kits Market by Region
• 5.3 Global Control Kits Market by Region
• 5.4 Global Template Kits Market by Region
• 5.5 Global Other Type Market by Region

Chapter 6. Global Sequencing Reagents Market by Technology

• 6.1 Global Next-Generation Sequencing Market by Region
• 6.2 Global Third Generation Sequencing Market by Region
• 6.3 Global Sanger Sequencing Market by Region

Chapter 7. Global Sequencing Reagents Market by Application

• 7.1 Global Oncology Market by Region
• 7.2 Global Reproductive Health Market by Region
• 7.3 Global Clinical Investigation Market by Region
• 7.4 Global Agrigenomics & Forensics Market by Region
• 7.5 Global Consumer Genomics Market by Region
• 7.6 Global Other Application Market by Region

Chapter 8. Global Sequencing Reagents Market by End Use

• 8.1 Global Academic Research Market by Region
• 8.2 Global Clinical Research Market by Region
• 8.3 Global Hospitals & Clinics Market by Region
• 8.4 Global Pharmaceutical & Biotechnology Companies Market by Region
• 8.5 Global Other End Use Market by Region

Chapter 9. Global Sequencing Reagents Market by Region

• 9.1 North America Sequencing Reagents Market
  • 9.1.1 North America Sequencing Reagents Market by Type
    • 9.1.1.1 North America Sequencing Kits Market by Country
    • 9.1.1.2 North America Library Kits Market by Country
    • 9.1.1.3 North America Control Kits Market by Country
    • 9.1.1.4 North America Template Kits Market by Country
    • 9.1.1.5 North America Other Type Market by Country
  • 9.1.2 North America Sequencing Reagents Market by Technology
    • 9.1.2.1 North America Next-Generation Sequencing Market by Country
    • 9.1.2.2 North America Third Generation Sequencing Market by Country
    • 9.1.2.3 North America Sanger Sequencing Market by Country
  • 9.1.3 North America Sequencing Reagents Market by Application
    • 9.1.3.1 North America Oncology Market by Country
    • 9.1.3.2 North America Reproductive Health Market by Country
    • 9.1.3.3 North America Clinical Investigation Market by Country
    • 9.1.3.4 North America Agrigenomics & Forensics Market by Country
    • 9.1.3.5 North America Consumer Genomics Market by Country
    • 9.1.3.6 North America Other Application Market by Country
  • 9.1.4 North America Sequencing Reagents Market by End Use
    • 9.1.4.1 North America Academic Research Market by Country
    • 9.1.4.2 North America Clinical Research Market by Country
    • 9.1.4.3 North America Hospitals & Clinics Market by Country
    • 9.1.4.4 North America Pharmaceutical & Biotechnology Companies Market by Country
    • 9.1.4.5 North America Other End Use Market by Country
  • 9.1.5 North America Sequencing Reagents Market by Country
    • 9.1.5.1 US Sequencing Reagents Market
      • 9.1.5.1.1 US Sequencing Reagents Market by Type
      • 9.1.5.1.2 US Sequencing Reagents Market by Technology
      • 9.1.5.1.3 US Sequencing Reagents Market by Application
      • 9.1.5.1.4 US Sequencing Reagents Market by End Use
    • 9.1.5.2 Canada Sequencing Reagents Market
      • 9.1.5.2.1 Canada Sequencing Reagents Market by Type
      • 9.1.5.2.2 Canada Sequencing Reagents Market by Technology
      • 9.1.5.2.3 Canada Sequencing Reagents Market by Application
      • 9.1.5.2.4 Canada Sequencing Reagents Market by End Use
    • 9.1.5.3 Mexico Sequencing Reagents Market
      • 9.1.5.3.1 Mexico Sequencing Reagents Market by Type
      • 9.1.5.3.2 Mexico Sequencing Reagents Market by Technology
      • 9.1.5.3.3 Mexico Sequencing Reagents Market by Application
      • 9.1.5.3.4 Mexico Sequencing Reagents Market by End Use
    • 9.1.5.4 Rest of North America Sequencing Reagents Market
      • 9.1.5.4.1 Rest of North America Sequencing Reagents Market by Type
      • 9.1.5.4.2 Rest of North America Sequencing Reagents Market by Technology
      • 9.1.5.4.3 Rest of North America Sequencing Reagents Market by Application
      • 9.1.5.4.4 Rest of North America Sequencing Reagents Market by End Use
• 9.2 Europe Sequencing Reagents Market
  • 9.2.1 Europe Sequencing Reagents Market by Type
    • 9.2.1.1 Europe Sequencing Kits Market by Country
    • 9.2.1.2 Europe Library Kits Market by Country
    • 9.2.1.3 Europe Control Kits Market by Country
    • 9.2.1.4 Europe Template Kits Market by Country
    • 9.2.1.5 Europe Other Type Market by Country
  • 9.2.2 Europe Sequencing Reagents Market by Technology
    • 9.2.2.1 Europe Next-Generation Sequencing Market by Country
    • 9.2.2.2 Europe Third Generation Sequencing Market by Country
    • 9.2.2.3 Europe Sanger Sequencing Market by Country
  • 9.2.3 Europe Sequencing Reagents Market by Application
    • 9.2.3.1 Europe Oncology Market by Country
    • 9.2.3.2 Europe Reproductive Health Market by Country
    • 9.2.3.3 Europe Clinical Investigation Market by Country
    • 9.2.3.4 Europe Agrigenomics & Forensics Market by Country
    • 9.2.3.5 Europe Consumer Genomics Market by Country
    • 9.2.3.6 Europe Other Application Market by Country
  • 9.2.4 Europe Sequencing Reagents Market by End Use
    • 9.2.4.1 Europe Academic Research Market by Country
    • 9.2.4.2 Europe Clinical Research Market by Country
    • 9.2.4.3 Europe Hospitals & Clinics Market by Country
    • 9.2.4.4 Europe Pharmaceutical & Biotechnology Companies Market by Country
    • 9.2.4.5 Europe Other End Use Market by Country
  • 9.2.5 Europe Sequencing Reagents Market by Country
    • 9.2.5.1 Germany Sequencing Reagents Market
      • 9.2.5.1.1 Germany Sequencing Reagents Market by Type
      • 9.2.5.1.2 Germany Sequencing Reagents Market by Technology
      • 9.2.5.1.3 Germany Sequencing Reagents Market by Application
      • 9.2.5.1.4 Germany Sequencing Reagents Market by End Use
    • 9.2.5.2 UK Sequencing Reagents Market
      • 9.2.5.2.1 UK Sequencing Reagents Market by Type
      • 9.2.5.2.2 UK Sequencing Reagents Market by Technology
      • 9.2.5.2.3 UK Sequencing Reagents Market by Application
      • 9.2.5.2.4 UK Sequencing Reagents Market by End Use
    • 9.2.5.3 France Sequencing Reagents Market
      • 9.2.5.3.1 France Sequencing Reagents Market by Type
      • 9.2.5.3.2 France Sequencing Reagents Market by Technology
      • 9.2.5.3.3 France Sequencing Reagents Market by Application
      • 9.2.5.3.4 France Sequencing Reagents Market by End Use
    • 9.2.5.4 Russia Sequencing Reagents Market
      • 9.2.5.4.1 Russia Sequencing Reagents Market by Type
      • 9.2.5.4.2 Russia Sequencing Reagents Market by Technology
      • 9.2.5.4.3 Russia Sequencing Reagents Market by Application
      • 9.2.5.4.4 Russia Sequencing Reagents Market by End Use
    • 9.2.5.5 Spain Sequencing Reagents Market
      • 9.2.5.5.1 Spain Sequencing Reagents Market by Type
      • 9.2.5.5.2 Spain Sequencing Reagents Market by Technology
      • 9.2.5.5.3 Spain Sequencing Reagents Market by Application
      • 9.2.5.5.4 Spain Sequencing Reagents Market by End Use
    • 9.2.5.6 Italy Sequencing Reagents Market
      • 9.2.5.6.1 Italy Sequencing Reagents Market by Type
      • 9.2.5.6.2 Italy Sequencing Reagents Market by Technology
      • 9.2.5.6.3 Italy Sequencing Reagents Market by Application
      • 9.2.5.6.4 Italy Sequencing Reagents Market by End Use
    • 9.2.5.7 Rest of Europe Sequencing Reagents Market
      • 9.2.5.7.1 Rest of Europe Sequencing Reagents Market by Type
      • 9.2.5.7.2 Rest of Europe Sequencing Reagents Market by Technology
      • 9.2.5.7.3 Rest of Europe Sequencing Reagents Market by Application
      • 9.2.5.7.4 Rest of Europe Sequencing Reagents Market by End Use
• 9.3 Asia Pacific Sequencing Reagents Market
  • 9.3.1 Asia Pacific Sequencing Reagents Market by Type
    • 9.3.1.1 Asia Pacific Sequencing Kits Market by Country
    • 9.3.1.2 Asia Pacific Library Kits Market by Country
    • 9.3.1.3 Asia Pacific Control Kits Market by Country
    • 9.3.1.4 Asia Pacific Template Kits Market by Country
    • 9.3.1.5 Asia Pacific Other Type Market by Country
  • 9.3.2 Asia Pacific Sequencing Reagents Market by Technology
    • 9.3.2.1 Asia Pacific Next-Generation Sequencing Market by Country
    • 9.3.2.2 Asia Pacific Third Generation Sequencing Market by Country
    • 9.3.2.3 Asia Pacific Sanger Sequencing Market by Country
  • 9.3.3 Asia Pacific Sequencing Reagents Market by Application
    • 9.3.3.1 Asia Pacific Oncology Market by Country
    • 9.3.3.2 Asia Pacific Reproductive Health Market by Country
    • 9.3.3.3 Asia Pacific Clinical Investigation Market by Country
    • 9.3.3.4 Asia Pacific Agrigenomics & Forensics Market by Country
    • 9.3.3.5 Asia Pacific Consumer Genomics Market by Country
    • 9.3.3.6 Asia Pacific Other Application Market by Country
  • 9.3.4 Asia Pacific Sequencing Reagents Market by End Use
    • 9.3.4.1 Asia Pacific Academic Research Market by Country
    • 9.3.4.2 Asia Pacific Clinical Research Market by Country
    • 9.3.4.3 Asia Pacific Hospitals & Clinics Market by Country
    • 9.3.4.4 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
    • 9.3.4.5 Asia Pacific Other End Use Market by Country
  • 9.3.5 Asia Pacific Sequencing Reagents Market by Country
    • 9.3.5.1 China Sequencing Reagents Market
      • 9.3.5.1.1 China Sequencing Reagents Market by Type
      • 9.3.5.1.2 China Sequencing Reagents Market by Technology
      • 9.3.5.1.3 China Sequencing Reagents Market by Application
      • 9.3.5.1.4 China Sequencing Reagents Market by End Use
    • 9.3.5.2 Japan Sequencing Reagents Market
      • 9.3.5.2.1 Japan Sequencing Reagents Market by Type
      • 9.3.5.2.2 Japan Sequencing Reagents Market by Technology
      • 9.3.5.2.3 Japan Sequencing Reagents Market by Application
      • 9.3.5.2.4 Japan Sequencing Reagents Market by End Use
    • 9.3.5.3 India Sequencing Reagents Market
      • 9.3.5.3.1 India Sequencing Reagents Market by Type
      • 9.3.5.3.2 India Sequencing Reagents Market by Technology
      • 9.3.5.3.3 India Sequencing Reagents Market by Application
      • 9.3.5.3.4 India Sequencing Reagents Market by End Use
    • 9.3.5.4 South Korea Sequencing Reagents Market
      • 9.3.5.4.1 South Korea Sequencing Reagents Market by Type
      • 9.3.5.4.2 South Korea Sequencing Reagents Market by Technology
      • 9.3.5.4.3 South Korea Sequencing Reagents Market by Application
      • 9.3.5.4.4 South Korea Sequencing Reagents Market by End Use
    • 9.3.5.5 Australia Sequencing Reagents Market
      • 9.3.5.5.1 Australia Sequencing Reagents Market by Type
      • 9.3.5.5.2 Australia Sequencing Reagents Market by Technology
      • 9.3.5.5.3 Australia Sequencing Reagents Market by Application
      • 9.3.5.5.4 Australia Sequencing Reagents Market by End Use
    • 9.3.5.6 Malaysia Sequencing Reagents Market
      • 9.3.5.6.1 Malaysia Sequencing Reagents Market by Type
      • 9.3.5.6.2 Malaysia Sequencing Reagents Market by Technology
      • 9.3.5.6.3 Malaysia Sequencing Reagents Market by Application
      • 9.3.5.6.4 Malaysia Sequencing Reagents Market by End Use
    • 9.3.5.7 Rest of Asia Pacific Sequencing Reagents Market
      • 9.3.5.7.1 Rest of Asia Pacific Sequencing Reagents Market by Type
      • 9.3.5.7.2 Rest of Asia Pacific Sequencing Reagents Market by Technology
      • 9.3.5.7.3 Rest of Asia Pacific Sequencing Reagents Market by Application
      • 9.3.5.7.4 Rest of Asia Pacific Sequencing Reagents Market by End Use
• 9.4 LAMEA Sequencing Reagents Market
  • 9.4.1 LAMEA Sequencing Reagents Market by Type
    • 9.4.1.1 LAMEA Sequencing Kits Market by Country
    • 9.4.1.2 LAMEA Library Kits Market by Country
    • 9.4.1.3 LAMEA Control Kits Market by Country
    • 9.4.1.4 LAMEA Template Kits Market by Country
    • 9.4.1.5 LAMEA Other Type Market by Country
  • 9.4.2 LAMEA Sequencing Reagents Market by Technology
    • 9.4.2.1 LAMEA Next-Generation Sequencing Market by Country
    • 9.4.2.2 LAMEA Third Generation Sequencing Market by Country
    • 9.4.2.3 LAMEA Sanger Sequencing Market by Country
  • 9.4.3 LAMEA Sequencing Reagents Market by Application
    • 9.4.3.1 LAMEA Oncology Market by Country
    • 9.4.3.2 LAMEA Reproductive Health Market by Country
    • 9.4.3.3 LAMEA Clinical Investigation Market by Country
    • 9.4.3.4 LAMEA Agrigenomics & Forensics Market by Country
    • 9.4.3.5 LAMEA Consumer Genomics Market by Country
    • 9.4.3.6 LAMEA Other Application Market by Country
  • 9.4.4 LAMEA Sequencing Reagents Market by End Use
    • 9.4.4.1 LAMEA Academic Research Market by Country
    • 9.4.4.2 LAMEA Clinical Research Market by Country
    • 9.4.4.3 LAMEA Hospitals & Clinics Market by Country
    • 9.4.4.4 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
    • 9.4.4.5 LAMEA Other End Use Market by Country
  • 9.4.5 LAMEA Sequencing Reagents Market by Country
    • 9.4.5.1 Brazil Sequencing Reagents Market
      • 9.4.5.1.1 Brazil Sequencing Reagents Market by Type
      • 9.4.5.1.2 Brazil Sequencing Reagents Market by Technology
      • 9.4.5.1.3 Brazil Sequencing Reagents Market by Application
      • 9.4.5.1.4 Brazil Sequencing Reagents Market by End Use
    • 9.4.5.2 Argentina Sequencing Reagents Market
      • 9.4.5.2.1 Argentina Sequencing Reagents Market by Type
      • 9.4.5.2.2 Argentina Sequencing Reagents Market by Technology
      • 9.4.5.2.3 Argentina Sequencing Reagents Market by Application
      • 9.4.5.2.4 Argentina Sequencing Reagents Market by End Use
    • 9.4.5.3 UAE Sequencing Reagents Market
      • 9.4.5.3.1 UAE Sequencing Reagents Market by Type
      • 9.4.5.3.2 UAE Sequencing Reagents Market by Technology
      • 9.4.5.3.3 UAE Sequencing Reagents Market by Application
      • 9.4.5.3.4 UAE Sequencing Reagents Market by End Use
    • 9.4.5.4 Saudi Arabia Sequencing Reagents Market
      • 9.4.5.4.1 Saudi Arabia Sequencing Reagents Market by Type
      • 9.4.5.4.2 Saudi Arabia Sequencing Reagents Market by Technology
      • 9.4.5.4.3 Saudi Arabia Sequencing Reagents Market by Application
      • 9.4.5.4.4 Saudi Arabia Sequencing Reagents Market by End Use
    • 9.4.5.5 South Africa Sequencing Reagents Market
      • 9.4.5.5.1 South Africa Sequencing Reagents Market by Type
      • 9.4.5.5.2 South Africa Sequencing Reagents Market by Technology
      • 9.4.5.5.3 South Africa Sequencing Reagents Market by Application
      • 9.4.5.5.4 South Africa Sequencing Reagents Market by End Use
    • 9.4.5.6 Nigeria Sequencing Reagents Market
      • 9.4.5.6.1 Nigeria Sequencing Reagents Market by Type
      • 9.4.5.6.2 Nigeria Sequencing Reagents Market by Technology
      • 9.4.5.6.3 Nigeria Sequencing Reagents Market by Application
      • 9.4.5.6.4 Nigeria Sequencing Reagents Market by End Use
    • 9.4.5.7 Rest of LAMEA Sequencing Reagents Market
      • 9.4.5.7.1 Rest of LAMEA Sequencing Reagents Market by Type
      • 9.4.5.7.2 Rest of LAMEA Sequencing Reagents Market by Technology
      • 9.4.5.7.3 Rest of LAMEA Sequencing Reagents Market by Application
      • 9.4.5.7.4 Rest of LAMEA Sequencing Reagents Market by End Use

Chapter 10. Company Profiles

• 10.1 Agilent Technologies, Inc.
  • 10.1.1 Company Overview
  • 10.1.2 Financial Analysis
  • 10.1.3 Segmental and Regional Analysis
  • 10.1.4 Research & Development Expense
  • 10.1.5 Recent strategies and developments:
    • 10.1.5.1 Acquisition and Mergers:
  • 10.1.6 SWOT Analysis
• 10.2 F. Hoffmann-La Roche Ltd.
  • 10.2.1 Company Overview
  • 10.2.2 Financial Analysis
  • 10.2.3 Segmental and Regional Analysis
  • 10.2.4 Research & Development Expense
  • 10.2.5 Recent strategies and developments:
    • 10.2.5.1 Partnerships, Collaborations, and Agreements:
    • 10.2.5.2 Product Launches and Product Expansions:
  • 10.2.6 SWOT Analysis
• 10.3 Danaher Corporation (Beckman Coulter, Inc.)
  • 10.3.1 Company Overview
  • 10.3.2 Financial Analysis
  • 10.3.3 Segmental and Regional Analysis
  • 10.3.4 Research & Development Expense
  • 10.3.5 SWOT Analysis
• 10.4 Abbott Laboratories
  • 10.4.1 Company Overview
  • 10.4.2 Financial Analysis
  • 10.4.3 Segmental and Regional Analysis
  • 10.4.4 Research & Development Expense
  • 10.4.5 Recent strategies and developments:
    • 10.4.5.1 Partnerships, Collaborations, and Agreements:
  • 10.4.6 SWOT Analysis
• 10.5 Bio-Rad laboratories, Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Financial Analysis
  • 10.5.3 Segmental and Regional Analysis
  • 10.5.4 Research & Development Expenses
  • 10.5.5 Recent strategies and developments:
    • 10.5.5.1 Partnerships, Collaborations, and Agreements:
    • 10.5.5.2 Product Launches and Product Expansions:
  • 10.5.6 SWOT Analysis
• 10.6 Quest Diagnostics Incorporated
  • 10.6.1 Company Overview
  • 10.6.2 Financial Analysis
  • 10.6.3 Segmental Analysis
  • 10.6.4 SWOT Analysis
• 10.7 Revvity, Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Financial Analysis
  • 10.7.3 Segmental and Regional Analysis
  • 10.7.4 Research & Development Expenses
  • 10.7.5 Recent strategies and developments:
    • 10.7.5.1 Partnerships, Collaborations, and Agreements:
  • 10.7.6 SWOT Analysis
• 10.8 Eurofins Scientific SE
  • 10.8.1 Company Overview
  • 10.8.2 Financial Analysis
  • 10.8.3 Regional Analysis
  • 10.8.4 Recent strategies and developments:
    • 10.8.4.1 Partnerships, Collaborations, and Agreements:
  • 10.8.5 SWOT Analysis
• 10.9 Hologic, Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Financial Analysis
  • 10.9.3 Segmental and Regional Analysis
  • 10.9.4 Research & Development Expenses
  • 10.9.5 Recent strategies and developments:
    • 10.9.5.1 Acquisition and Mergers:
  • 10.9.6 SWOT Analysis
• 10.10. Illumina, Inc.
  • 10.10.1 Company Overview
  • 10.10.2 Financial Analysis
  • 10.10.3 Segment and Regional Analysis
  • 10.10.4 Research & Development Expense
  • 10.10.5 Recent strategies and developments:
    • 10.10.5.1 Product Launches and Product Expansions:3
  • 10.10.6 SWOT Analysis

Chapter 11. Winning Imperatives of Sequencing Reagents Market